Position
Quantbot Technologies LP in Crispr Therapeutics Ag
Back to the book · All holders of CRSP
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$6.81K$52.44 → $47.57
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.18K | $114.5K | — | — | — | 0.0% |
| Q1 2026 | 1.4K | $66.5K | $47.57 | −$6.81K | −$41.2K | 0.0% |